MedTrace Logo

Product Performance of a New Silicone Hydrogel Contact Lens

NCT04901897 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 805

Last updated 2021-07-08

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the product performance of kalifilcon A, compared to the Johnson \& Johnson Acuvue Oasys® 1-Day with HydraLuxe™ (senofilcon A) daily disposable contact lens and Alcon DAILIES TOTAL1® (delefilcon A) daily disposable contact lenses when worn by current soft contact lens wearers on a daily disposable wear basis.

Conditions

  • Myopia

Interventions

DEVICE

kalifilcon A

kalifilcon A daily disposable contact lens

DEVICE

delefilcon A

DAILIES TOTAL1® (delefilcon A) daily disposable contact lenses

DEVICE

senofilcon A

Acuvue Oasys® 1-Day with HydraLuxe™ (senofilcon A) daily disposable contact lens

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Robert Steffen · Bausch & Lomb Incorporated

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-31
Primary Completion
2019-10-09
Completion
2019-10-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04901897 on ClinicalTrials.gov